Smart cloud health listed: with a market value of HK $15billion, SIG Jingwei and Jingxin fund are shareholders

RedI network Lei Jianping 7 month 6 Reported Wednesday

Zhiyun Health Technology Group （ abbreviation ：“ Zhiyun health ”, Ticker ：“09955”） Listed on the Hong Kong Stock Exchange today , Issue price 30.5 The Hong Kong dollar , The net amount raised is 4.82 Million Hong Kong dollars .

Cornerstone investors of Zhiyun health include pharmaceutical giant Sanofi （Sanofi）、Harvest、 Yangzijiang Hong Kong 、Tasly, Co subscription 1158.7 Thousands of stocks , subscription 3.53 Million Hong Kong dollars , Of the total fund-raising 60.96%.

The opening price of Zhiyun health is 30.5 The Hong Kong dollar , Equal to the issue price ; The closing price is 25.6 The Hong Kong dollar , Lower than the issue price 16%; At the closing price , The market value of Zhiyun health is 150.28 Million Hong Kong dollars .

Annual revenue is close to 18 Billion

Zhiyun health was founded in 2014 year 12 month , It is a one-stop chronic disease management and intelligent medical platform .

Kuang Ming, who studied at Cambridge University , He was once arranged to intern in a hospital . He noticed that before the patient arrived at the hospital, the doctor had learned the patient's physical signs , After the meeting, the doctor finished the diagnosis and treatment as easily and happily as usual and adjusted the medication plan .

How can doctors complete diagnosis and treatment quickly but accurately , This aroused Kuang Ming's curiosity . actually , The patient has a chronic disease , The key to chronic disease treatment is to understand patients' habits , The reason why doctors can make accurate diagnosis is that they know enough about patients , This is also the key to the treatment of chronic diseases .

Inspired by Kuang Ming, he planted the seeds of building a Chinese style chronic disease management , After returning home , Kuang Ming started to create Zhiyun health .

How can smart cloud health stand on the digital health market ？

Key factor one ： The company's market positioning is accurate , Jianzhi chronic disease management digital market . China is the country with the largest number of chronic disease patients in the world , Facing the uneven distribution of medical resources , Poor medical experience and other problems . What is more ,2020 In, the average offline patient outpatient service in China 3 Hours , The doctor's diagnosis time only occupies 8 minute .

Besides , People with chronic diseases have non serious early symptoms , And need a long management cycle . How to help chronic patients with high frequency and efficiency , Become a social issue .

With the popularity of intelligent wearable devices , Patients can not only go to the hospital for a long time to queue up for diagnosis and treatment , It's about being able to access self-health management tools , Check your health at any time . therefore , The digital health management scheme is especially suitable for people with chronic diseases .

Zhiyun health aims at all major participants in the medical value chain （ Including hospitals 、 The pharmacy 、 Pharmaceutical companies 、 Patients and doctors ）, Provide them with comprehensive services throughout the life cycle of digital chronic disease management .

Key factor 2 ： On 2016 In, the hospital first strategy was established , And stick to it till now .

Different from almost all existing internet medical enterprises , I didn't choose to burn money for e-commerce traffic and GMV, Zhiyun health was established very early “ Hospitals first ”, This extremely difficult but correct strategy . The company silently uses Saas Systems and services improve the efficiency and effectiveness of hospital treatment and management in chronic hospitals , Provide assistance for the evolution and upgrading of China's medical system , Work hard is 6 year .

Key factor 3 ： The business model of the company has “ Flywheel effect ”, The potential for growth is huge .

Zhiyun health does not stop at the hospital market , The company has expanded its business model from inside the hospital to outside the hospital , Expand from hospitals to other key players , Further expand the audience , Treatment scenarios covering the whole life cycle of people with chronic diseases , Raise the upper limit of the company's development .

In the market outside the hospital , Zhiyun Health launched drugstore SaaS service , Such as Zhiyun's consultation , And achieved nearly in two years 18 The installed capacity of 10000 drugstores .

at present , Zhiyun health has passed the independent research and development of the hospital SaaS System 、 The pharmacy SaaS System and Internet hospital platform , For thousands of hospitals across the country , Hundreds of thousands of pharmacies provide services , radiation 5 Billion people with chronic diseases .

The revenue of Zhiyun health technology group is divided into hospital solutions 、 Pharmacy solutions 、 Personal chronic disease management solutions and others .

The prospectus shows , Zhiyun health 2019 year 、2020 year 、2021 The annual revenue is 5.24 One hundred million yuan 、8.39 One hundred million yuan 、17.57 One hundred million yuan ; The operating losses are respectively 1.8 One hundred million yuan 、8.37 One hundred million yuan 、6.96 One hundred million yuan ; The losses during the period were 5.65 One hundred million yuan 、28.97 One hundred million yuan 、41.53 One hundred million yuan .

Zhiyun health 2019 year 、2020 year 、2021 Adjusted losses for the year 1.5 One hundred million yuan 、6.36 One hundred million yuan 、4.44 One hundred million yuan .

Sunshine life insurance and Ping An venture capital are shareholders

The executive director of Zhiyun health is Kuang Ming , The non-executive director is lijiacong ; The independent non-executive director is Dr. hongweili 、 Zhang Saiyin 、Ang Khai Meng.

2018 year , Zhiyun completed the task healthily C-2 Round of funding , The total amount raised is about 3.45 One hundred million yuan .

2019 year , complete C-3 Wheel and D Round of funding , The total amount raised is about 4200 Ten thousand dollars and 9400 Thousands of dollars .

2020 year , complete D+ Wheel and E Round of funding , Total amount raised 4400 Ten thousand dollars and 6500 Thousands of dollars .

IPO front , Zhiyun health Co., Ltd. holds shares of 15.74%,Prime Forest Asset Limited The shareholding is 12.91%, Shanghai Qiji technology partnership （ Limited partnership ） The shareholding is 5.66%;

SIG Global The shareholding is 5.56%,IDG The shareholding is 5.35%; The shareholding of sunshine life insurance is 4.47%, Pu Lin fund holds 2.78%, Jingwei Chuangda's subsidiary Tembusu HZ II Limited The shareholding is 3.1%;

Under CICC Moon Technology Limited holding 3.32%, Under Ping An venture capital INNOVAC The shareholding is 3.34%,Lionet Fund The shareholding is 4.21%.

Xuchuansheng, founding managing partner of Jingwei venture capital, said ：“ Congratulations on Zhiyun's healthy completion of the Hong Kong Stock Exchange IPO. We from 2015 In, he has led the investor in the round of angels to invest until now , Accompany the company for seven years , Witnessed the rapid iteration and continuous innovation of the team under the leadership of the founder Mr. Kuang Ming . From the launch of the first domestic hospital with digitalized and standardized chronic disease management process SaaS product , To become the largest digital diagnosis and treatment service network of chronic diseases in China , Then to the deep digital marketing cooperation with head pharmaceutical enterprises, leading the industry , The company has built a one-stop whole industry chain service platform in the field of chronic diseases such as diabetes .”

Xu Chuansheng said ：“ We expect more and more Jingwei invested medical companies represented by Zhiyun health to usher in important milestones in the next two to three years , Become an important participant in the transformation and upgrading of China's medical industry chain , Service doctor 、 Patients benefit .”

IPO after , Zhiyun health Co., Ltd. holds shares of 15.23%,Prime Forest Asset Limited The shareholding is 12.49%, Shanghai Qiji technology partnership （ Limited partnership ） The shareholding is 5.66%;

SIG Global The shareholding is 5.38%,IDG The shareholding is 5.18%; The shareholding of sunshine life insurance is 4.32%, Pu Lin fund holds 2.68%, Jingwei Chuangda's subsidiary Tembusu HZ II Limited The shareholding is 3%;

Under CICC Moon Technology Limited holding 3.21%, Under Ping An venture capital INNOVAC The shareholding is 3.23%,Lionet Fund The shareholding is 4.07%,SUNNY SPEED The shareholding is 2.84%, Shanghai Runmin information technology holds 2.48%.

———————————————

Lei Di was founded by Lei Jianping, a senior media person , If reproduced, please indicate the source .